Skip to main content

Advertisement

SpringerLink
Log in

Association of estrogen receptor β and estrogen-related receptor α gene polymorphisms with bone mineral density in postmenopausal women

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The aim of the study was to investigate the possible association of AluI and RsaI polymorphisms of estrogen receptor β (ER-β) gene and 23-bp nucleotide repeat polymorphism of estrogen-related receptor α (ERRα) gene with bone mineral density (BMD) in postmenopausal Egyptian women. Two-hundred postmenopausal osteoporotic women as cases and 180 healthy age-matched postmenopausal women as controls were genotyped by PCR fragment length polymorphism for AluI, allele-specific PCR for RsaI, and by sizing of PCR products on agarose gels for ERRα repeats. sRANKL levels were estimated by ELISA. BMD measurements for spine and femoral neck were performed by dual energy X-ray absorptiometry. A significant difference between women with osteoporosis and controls regarding allele and genotype distributions of AluI G/A (OR 2.37, 95 % CI 1.77–3.18 and p < 0.001 for A allele) and ERRα polymorphisms (for the two repeats allele OR 2.08, 95 % CI 1.09–4.00, and p = 0.02). Osteoporotic women with the AluI AA + GA genotype or with the EERα 2,2 genotype had significantly lower BMD than did women with the other genotypes. Moreover, there was a significant increase of the mean values of sRANKL in carriers of AluI A, RsaI A alleles and in patients having 2,2 genotypes of ERRα (p < 0.001, p < 0.001, p = 0.02, respectively). We demonstrated an association of ER-β AluI G/A and ERRα 23-repeats polymorphisms with BMD in postmenopausal Egyptian women. A possible effect of ER-β and ERRα polymorphisms on the levels of sRANKL was estimated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD (2007) Low bone mineral density and fracture burden in postmenopausal women. CMAJ 177:575–580

    Article  PubMed Central  PubMed  Google Scholar 

  2. You L, Chen L, Pan L, Chen JY (2013) New insights into the gene function of osteoporosis. Front Biosci 1:1088–1097 (Landmark Ed)

    Article  Google Scholar 

  3. Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318–3325

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Bord S, Horner A, Beavan S, Compston J (2001) Estrogen receptors alpha and beta are differentially expressed in developing human bone. J Clin Endocrinol Metab 86:2309–2314

    CAS  PubMed  Google Scholar 

  5. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjöld M, Gustafsson JA (1997) Human estrogen receptorbeta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 82:4258–4265

    CAS  PubMed  Google Scholar 

  6. Gennari L, Merlotti D, De Paola V, Calabrò A, Becherini L, Martini G, Nuti R (2005) Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGe review. Am J Epidemiol 161:307–320

    Article  CAS  PubMed  Google Scholar 

  7. Jeedigunta Y, Reddy PR, Kolla VK, Munshi A, Ananthapur V, Narasimulu G, Akka J (2010) Association of estrogen receptor α gene polymorphisms with BMD and their effect on estradiol levels in pre- and postmenopausal women in south Indian population from Andhra Pradesh. Clin Chim Acta 411:597–600

    Article  CAS  PubMed  Google Scholar 

  8. Tanriover MD, Tatar GB, Uluturk TD, Erden DD, Tanriover A, Kilicarslan A, Oz SG, Yurter HE, Sozen T, Guvenm GS (2010) Evaluation of the effects of vitamin D receptor and estrogen receptor 1 gene polymorphisms on bone mineral density in postmenopausal women. Clin Rheumatol 29:1285–1293

    Article  PubMed  Google Scholar 

  9. Wang KJ, Shi DQ, Sun LS, Jiang X, Lü YY, Dai J, Chen DY, Xu ZH, Jiang Q (2012) Association of estrogen receptor alpha gene polymorphisms with bone mineral density: a meta-analysis. Chin Med J 125:2589–2597 (Engl)

    Google Scholar 

  10. Honma N, Mori S, Zhou H, Ikeda S, Mieno MN, Tanaka N, Takubo K, Arai T, Sawabe M, Muramatsu M, Ito H (2013) Association between estrogen receptor-β dinucleotide repeat polymorphism and incidence of femoral fracture. J Bone Miner Metab 31:96–101

    Article  CAS  PubMed  Google Scholar 

  11. Geng L, Yao Z, Yang H, Luo J, Han L, Lu Q (2007) Association of CA repeat polymorphism in estrogen receptor beta gene with postmenopausal osteoporosis in Chinese. J Genet Genomics 34:868–876

    Article  CAS  PubMed  Google Scholar 

  12. Scariano JK, Simplicio SG, Montoya GD, Garry PJ, Baumgartner RN (2004) Estrogen receptor beta dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women. Calcif Tissue Int 74:501–508

    Article  CAS  PubMed  Google Scholar 

  13. Curro M, Marini H, Alibrandi A, Ferlazzo N, Condello S, Polito F, Adamo EB, Atteritano M, Anna RD, Altavilla D, Bitto A, Squadrito F, Ientile R, Caccamo D (2011) The ESR2 AluI gene polymorphism is associated with bone mineral density in postmenopausal women. J Steroid Biochem Mol Biol 127:413–417

    Article  CAS  PubMed  Google Scholar 

  14. Arko B, Prezelj J, Komel R, Kocijancic A, Marc J (2002) No major effect of estrogen receptor beta gene RsaI polymorphism on bone mineral density and response to alendronate therapy in postmenopausal osteoporosis. J Steroid Biochem Mol Biol 81:147–152

    Article  CAS  PubMed  Google Scholar 

  15. Bonnelye E, Aubin JE (2005) Estrogen receptor-related receptor alpha: a mediator of estrogen response in bone. J Clin Endocrinol Metab 90:3115–3121

    Article  CAS  PubMed  Google Scholar 

  16. Laganière J, Tremblay GB, Dufour CR, Giroux S, Rousseau F, Giguère V (2004) Polymorphic autoregulatory hormoneresponse element in the human estrogen related receptor α (ERRα) promoter dictates PGC-1α control of ERRα expression. J Biol Chem 279:18504–18510

    Article  PubMed  Google Scholar 

  17. Laflamme N, Giroux S, Loredo-Osti JC, Elfassihi L, Dodin S, Blanchet C, Morgan K, Giguère V, Rousseau F (2005) A frequent regulatory variant of the estrogen-related receptor alpha gene associated with BMD in French-Canadian premenopausal women. J Bone Miner Res 20:938–944

    Article  CAS  PubMed  Google Scholar 

  18. Giroux S, Elfassihi L, Cole DE, Rousseau F (2008) Replication of associations between LRP5 and ESRRA variants and bone density in premenopausal women. Osteoporos Int 19:1769–1775

    Article  CAS  PubMed  Google Scholar 

  19. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:1221–1230

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Boyce BF, Xing L (2008) Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139–146

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Kanamaru F, Iwai H, Ikeda T, Nakajima A, Ishikawa I, Azuma M (2004) Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells. Immunol Lett 94:239–246

    Article  CAS  PubMed  Google Scholar 

  22. World Health Organization. WHO scientific group on the assessment of osteoporosis at primary health care level: summary meeting report. Available at:http://www.who.int/chp/topics/Osteoporosis.pdf. Accessed 6 Feb 2012

  23. Meng J, Mu X, Wang YM (2013) Influence of the XbaI polymorphism in the estrogen receptor-α gene on human spermatogenic defects. Genet Mol Res 12:1808–1815

    Article  CAS  PubMed  Google Scholar 

  24. Silva RC, Costa IR, Bordin BM, Silva CT, Souza SR, Júnior CL, Frare AB, Moura KK (2011) RsaI polymorphism of the ERβ gene in women with endometriosis. Genet Mol Res 10:465–470

  25. Arts J, Kuiper GG, Janssen JM, Gustafsson JA, Löwik CW, Pols HA, van Leeuwen JP (1997) Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SVHF cells. Endocrinology 138:5067–5070

    CAS  PubMed  Google Scholar 

  26. Vico L, Vanacker JM (2010) Sex hormones and their receptors in bone homeostasis :insights from genetically modified mouse models. Osteoporos Int 21:365–372

    Article  CAS  PubMed  Google Scholar 

  27. An J, Ribeiro RCJ, Webb P, Gustafsson JA, Kushner PJ, Baxter JD, Leitman DC (1999) Estradiol repression of tumour necrosisfactor-α transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci USA 96:15161–15166

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Efstathiadou Z, Koukoulis G, Stakias N, Challa A, Zintzaras E, Tsatsoulis A (2006) Correlation of estrogen receptor beta gene polymorphisms with spinal bonemineral density in peri- and post-menopausal Greek women. Maturitas 53:380–385

    Article  CAS  PubMed  Google Scholar 

  29. Ichikawa S, Koller DL, Peacock M, Johnson ML, Lai D, Hui SL, Johnston CC, Foroud TM, Econs MJ (2005) Polymorphisms in the estrogen receptor beta (ESR2) gene are associated with bone mineral density in Caucasian men and women. J Clin Endocrinol Metab 90:5921–5927

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Khosla S, Riggs BL, Atkinson EJ, Oberg AL, Mavilia C, Del Monte F, Melton LJ, Brandi ML (2004) Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men. J Clin Endocrinol Metab 89:1808–1816

    Article  CAS  PubMed  Google Scholar 

  31. Putnik M, Zhao C, Gustafsson JA, Dahlman-Wright K (2009) Effects of two common polymorphisms in the 3′untranslated regions of estrogen receptor β on mRNA stability and translatability. BMC Genet 10:55. doi:10.1186/1471-2156-10-55

    Article  PubMed Central  PubMed  Google Scholar 

  32. Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, Gaudio A, Mazzaferro S, Frisina A, Frisina N, Lubrano C, Bonaiuto M, D’Anna R, Cannata ML, Corrado F, Cancellieri F, Faraci M, Marini R, Adamo EB, Wilson S, Squadrito F (2008) OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. J Bone Miner Res 23:715–720

    Article  CAS  PubMed  Google Scholar 

  33. Bitto A, Polito F, Squadrito F, Marini H, D’Anna R, Irrera N, Minutoli L, Granese R, Altavilla D (2010) Genistein aglycone: a dual mode of actionanti-osteoporotic soy isoflavone rebalancing bone turnover towards bone formation. Curr Med Chem 17:3007–3018

    Article  CAS  PubMed  Google Scholar 

  34. Tremblay GB, Kunath T, Bergeron D, Lapointe L, Champigny C, Bader JA, Rossant J, Giguère V (2001) Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR beta. Genes Dev 15:833–838

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Greschik H, Flaig R, Renaud JP, Moras D (2004) Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity. J Biol Chem 279:33639–33646

    Article  CAS  PubMed  Google Scholar 

  36. Khosla S (2001) Minireview: the OPG/RANKL/RANK system. Endocrinology 142:5050–5055

    Article  CAS  PubMed  Google Scholar 

  37. Oelzner P, Franke S, Lehmann G, Eidner T, Müller A, Wolf G, Hein G (2007) Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis-relationship with bone mineral density, disease activity and bone turnover. Clin Rheumatol 26:2127–2135

    Article  CAS  PubMed  Google Scholar 

  38. Gurban CV, Mederle O (2011) The OPG/RANKL system and zinc ions are promoters of bone remodeling by osteoblast proliferation in postmenopausal osteoporosis. Rom J Morphol Embryol 52:1113–1119

    PubMed  Google Scholar 

  39. Lacey DL, Boyle WJ, Simonet WS, Kostenuik PJ, Dougall WC, Sullivan JK, San Martin J, Dansey R (2012) Bench to bedside:elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat Rev Drug Discov 11:401–419

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Amira Shoukry

  2. Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Sally M. Shalaby & Rasha L. Etewa

  3. Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Hanan S. Ahmed

  4. Radiology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Hossam M. Abdelrahman

Authors
  1. Amira Shoukry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sally M. Shalaby
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rasha L. Etewa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hanan S. Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hossam M. Abdelrahman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sally M. Shalaby.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shoukry, A., Shalaby, S.M., Etewa, R.L. et al. Association of estrogen receptor β and estrogen-related receptor α gene polymorphisms with bone mineral density in postmenopausal women. Mol Cell Biochem 405, 23–31 (2015). https://doi.org/10.1007/s11010-015-2391-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-015-2391-5

Keywords

Search

Navigation